Jeena Sikho Lifecare Limited (JSLL) Earnings Call Transcript
February 9, 2026
Earnings Call Speaker Segments
Ladies and gentlemen, good day, and welcome to the Jeena Sikho Lifecare Limited Q3 FY '26 Earnings Call. [Operator Instructions] I now hand the conference over to Mr. Ranvir Singh. Thank you, and over to you.
Yes. Thank you, moderator. So on behalf of Jeena Sikho Lifecare Limited, I extend a very warm welcome to all participants on the Q3 FY '26 financial results discussion call. Joining us today on the call are Mr. Manish Grover Ji, popularly known as Acharya Ji, he is the Managing Director; Mr. Nanak Chand, he is the CFO. Before we begin, I would like to draw your attention to the standard disclaimer. This call may contain certain forward-looking statements, which are based on management's current expectations and beliefs. These statements are subject to risks and uncertainties, and actual results may differ materially. With that, I would now like to hand over the call to Acharya Manish Ji for his opening remarks. Over to you, sir.
[Foreign Language]
Thank you, Manish sir. Good afternoon, everyone. I will now take through the key financial highlights for Q3 FY '26 prepared in accordance with the Ind AS following our migration to the main board in August 2025. For the quarter, our revenue from the operations stood INR 221.7 crores, up by 92% year-to-year and 17% Q-to-Q. Gross profit increased to INR 197.5 crores with an improved gross margin 89%. Our EBITDA came in at INR 100.8 crores, recorded 240% Y-on-Y growth with margins at 45%. Profit after tax stood at INR 66.7 crores, reflecting a 405% Y-o-Y growth. Our basic EPS for the quarter is INR 5.37. The improvement in the profitability was driven by the higher operating leverage from the increased patient volume, strong contribution from the high-margin products and sales, controlled operating expense despite our network expansion. Our balance sheet remains strong with prudent financial management, improving cash flow and capital-light expansion strategy supporting the superior ROCE. With this, we open the floor for a question-and-answer session. Thank you.
[Operator Instructions] We have the first question from the line of [ Priyanshu Jain ] from [indiscernible].
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language] Okay.
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
We have the next question from the line of [ Akshay from AK Investment ].
[Foreign Language] We will do around INR 750 crores [Foreign Language]. Already we have done INR 586 crores in 9 months of FY '26.
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Operator Instructions] We have the next question from the line of [ Abhishek Sengupta from AB Capital ].
Am I audible?
Yes, we can hear you.
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
We have the next question from the line of [ Akhilesh Rawat from Vedanta Vision ].
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
We have the next question from the line of [ Shubanu from Three Head Capital ].
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
We have the next question from the line of [ Praveen Kumar from Praveen Investments ].
Can you hear me?
[Foreign Language]
Sir, I have 2 questions. Can you tell me what percentage of your patients are recurring? That's the first question. And second question is a follow-up on your previous comments. You said you are in the...
[Foreign Language]
Yes, yes. Can you hear me properly now?
Yes, yes.
Okay. Sir, my first question is what is the percentage of your recurring patients.
[Foreign Language]
Yes, yes.
[Foreign Language]
Okay, understood. Sir, my second question is on your previous comment. You said you have piled up so much of cash and planning for some acquisitions [ and team engagement ]. Can you comment more on that, please? Where are we and what are those plans too?
[Foreign Language]
We have the next question from the line of [ Deepak Krithy from Wealth Investment ].
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
We have the next question from the line of [ Omkar Ji from Free Investment ].
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
We have the next question from the line of Amit Jeswani from Stallion Asset.
[Foreign Language]
[Foreign Language]
Done. Done, sir. 100%. [Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
I will see you, sir. I will see you there. [Foreign Language]
[Foreign Language]
Thank you, sir. Thank you so much, sir. [Foreign Language] How will you get there? [Foreign Language] Just thinking. [Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
Got it. [Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
Wow.
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language] You have not gone and opened new stores. [Foreign Language]
[Foreign Language]
Right. That's a very smart way of thinking. [Foreign Language]
[Foreign Language]
[Foreign Language] Super, super. [Foreign Language]
[Foreign Language]
Done, sir. Done, sir.
We have the next question from the line of [ Ankit from Fusion Capital ].
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
We have the next question from the line of [ Harish Kumar from Nirmal Bang ].
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
We have the next question from the line of [ Pratik Tandel from Qode Advisors LLP ].
Am I audible?
[Foreign Language]
[Foreign Language]
[Foreign Language]
Yes, sir. We are maintaining the sale proportion of the product as well as the government scenarios. We are maintaining the 3%...
41% and 54%.
We sustained on the same margin.
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
We have the next question from the line of [ Amit Agarwal ], an individual investor.
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
We have the next question from the line of [ Mohan Agarwal ], an investor.
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
Next question is from the line of they [ Sandeep Burlota from TechnoFunda ].
[Foreign Language]
[Foreign Language]
Good. Congratulations. This is the [ Entarro ] partnership, right?
[Foreign Language]
[Foreign Language]. Are they -- I know they go through the ICMR route. Are they patented [indiscernible]? [Foreign Language]
Yes. [Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
[Foreign Language]
Got it, sir.
[Foreign Language]
[Foreign Language]
[Foreign Language]
Ladies and gentlemen, that will be the last question for today. I now hand the conference over to the management for closing comments.
[Foreign Language]
Sir, that was the last question. You can go ahead for the closing comments.
Yes, sir. Thank you. [Foreign Language]
Yes, sir.
[Foreign Language] Health is actual real wealth. [Foreign Language]
Thank you very much. On behalf of Nuvama Wealth, that concludes this conference. Thank you for joining us, and you may now disconnect your lines. Thank you.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Jeena Sikho Lifecare Limited transcript - plus 252,000+ transcripts from 12,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Jeena Sikho Lifecare Limited earnings transcripts and 252,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $105 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.